Cargando…

Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus

BACKGROUND: Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden. METHODS: 106...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoke, Matthias, Schillinger, Martin, Minar, Erich, Goliasch, Georg, Binder, Christoph J., Mayer, Florian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626411/
https://www.ncbi.nlm.nih.gov/pubmed/31299990
http://dx.doi.org/10.1186/s12933-019-0895-0
_version_ 1783434572621414400
author Hoke, Matthias
Schillinger, Martin
Minar, Erich
Goliasch, Georg
Binder, Christoph J.
Mayer, Florian J.
author_facet Hoke, Matthias
Schillinger, Martin
Minar, Erich
Goliasch, Georg
Binder, Christoph J.
Mayer, Florian J.
author_sort Hoke, Matthias
collection PubMed
description BACKGROUND: Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden. METHODS: 1065 patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality. RESULTS: During a median of 11.8 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. Diabetes and glycohemoglobin A1c (Hba1c) levels were significantly associated with mortality. Diabetes displayed an independent risk for all-cause (adjusted HR 1.62; 95% CI 1.35–1.94) and cardiovascular death (adjusted HR 1.75, 95% CI 1.40–2.19). The adjusted hazard ratio per increase of 1% of Hba1c levels was 1.21 (P < 0.01) for all-cause and 1.31 (P < 0.01) for cardiovascular mortality, respectively. Patients with diabetes mellitus and a higher degree of carotid stenosis and were at great risk of adverse outcome. Only 21% of the asymptomatic diabetic patients with carotid narrowing over 50% survived, whereas 62% of the patients without diabetes and with carotid atherosclerosis below 50% were still alive after 12-years of follow-up. The high risk for all-cause and cardiovascular death of these patients remained significant after adjustment for various established cardiovascular risk factors in multivariable regression analysis (adjusted hazard ratio 2.4, P < 0.001; compared to patients without diabetes and < 50% carotid atherosclerosis). CONCLUSION: Diabetic patients with carotid stenosis ≥ 50% are at exceptional high risk for all-cause and cardiovascular death. Thus, routinely ultrasound investigation of the carotid arteries might be a valuable prognostic tool for patients with diabetes mellitus.
format Online
Article
Text
id pubmed-6626411
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66264112019-07-23 Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus Hoke, Matthias Schillinger, Martin Minar, Erich Goliasch, Georg Binder, Christoph J. Mayer, Florian J. Cardiovasc Diabetol Original Investigation BACKGROUND: Experimental and clinical data indicate a major influence of diabetes on atherogenesis. We aimed to assess whether the effect of diabetes on long-term mortality in asymptomatic patient with carotid stenosis is contingent upon the degree of the carotid atherosclerotic burden. METHODS: 1065 patients with neurological asymptomatic carotid atherosclerosis as evaluated by duplex sonography were prospectively followed for cause-specific mortality. RESULTS: During a median of 11.8 years, a total of 549 deaths, including 362 cardiovascular deaths, were recorded. Diabetes and glycohemoglobin A1c (Hba1c) levels were significantly associated with mortality. Diabetes displayed an independent risk for all-cause (adjusted HR 1.62; 95% CI 1.35–1.94) and cardiovascular death (adjusted HR 1.75, 95% CI 1.40–2.19). The adjusted hazard ratio per increase of 1% of Hba1c levels was 1.21 (P < 0.01) for all-cause and 1.31 (P < 0.01) for cardiovascular mortality, respectively. Patients with diabetes mellitus and a higher degree of carotid stenosis and were at great risk of adverse outcome. Only 21% of the asymptomatic diabetic patients with carotid narrowing over 50% survived, whereas 62% of the patients without diabetes and with carotid atherosclerosis below 50% were still alive after 12-years of follow-up. The high risk for all-cause and cardiovascular death of these patients remained significant after adjustment for various established cardiovascular risk factors in multivariable regression analysis (adjusted hazard ratio 2.4, P < 0.001; compared to patients without diabetes and < 50% carotid atherosclerosis). CONCLUSION: Diabetic patients with carotid stenosis ≥ 50% are at exceptional high risk for all-cause and cardiovascular death. Thus, routinely ultrasound investigation of the carotid arteries might be a valuable prognostic tool for patients with diabetes mellitus. BioMed Central 2019-07-12 /pmc/articles/PMC6626411/ /pubmed/31299990 http://dx.doi.org/10.1186/s12933-019-0895-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Hoke, Matthias
Schillinger, Martin
Minar, Erich
Goliasch, Georg
Binder, Christoph J.
Mayer, Florian J.
Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
title Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
title_full Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
title_fullStr Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
title_full_unstemmed Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
title_short Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
title_sort carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626411/
https://www.ncbi.nlm.nih.gov/pubmed/31299990
http://dx.doi.org/10.1186/s12933-019-0895-0
work_keys_str_mv AT hokematthias carotidultrasoundinvestigationasaprognostictoolforpatientswithdiabetesmellitus
AT schillingermartin carotidultrasoundinvestigationasaprognostictoolforpatientswithdiabetesmellitus
AT minarerich carotidultrasoundinvestigationasaprognostictoolforpatientswithdiabetesmellitus
AT goliaschgeorg carotidultrasoundinvestigationasaprognostictoolforpatientswithdiabetesmellitus
AT binderchristophj carotidultrasoundinvestigationasaprognostictoolforpatientswithdiabetesmellitus
AT mayerflorianj carotidultrasoundinvestigationasaprognostictoolforpatientswithdiabetesmellitus